Repaglinide Tablets 1 Mg

Repaglinide Tablets 1 Mg

Repaglinide Tablets 1 Mg is an oral anti-diabetic medication used for the management of type 2 diabetes mellitus. It belongs to the meglitinide class, which helps control blood sugar levels by stimulating rapid insulin release from the pancreas. This strength is commonly prescribed when a lower dose is insufficient for glycemic control. It is particularly effective in managing post-meal blood sugar spikes and is often used along with diet and exercise. In treatment plans, higher strengths like Repaglinide Tablets 2 Mg may be required, while advanced therapies such as Rybelsus 14 Mg – Semaglutide Tablets are used for improved glucose control.

Mechanism of Action

Rapid Insulin Secretion

Repaglinide stimulates insulin release from pancreatic beta cells in response to meals.

Postprandial Glucose Control

This helps reduce blood sugar spikes after eating. For clinical insights, refer to American Diabetes Association (ADA) and for safety guidance, consult Mayo Clinic – Repaglinide Information.

Medical Uses

Repaglinide Tablets 1 Mg is used for:

• Type 2 diabetes mellitus
• Post-meal blood sugar control
• Combination therapy with other antidiabetic medications

It is ideal for patients needing flexible meal-time glucose management.

Dosage and Administration

Repaglinide Tablets 1 Mg is usually taken 15–30 minutes before meals, as prescribed by a healthcare provider. The dosage may be adjusted based on blood sugar levels and response. In clinical practice, Repaglinide Tablets 2 Mg may be used for stronger glucose control, while Rybelsus 14 Mg – Semaglutide Tablets is an alternative option for advanced diabetes management.

Clinical Effectiveness

Clinical studies show that repaglinide effectively reduces post-meal glucose levels and improves overall glycemic control when used consistently.

Safety and Side Effects

Common Side Effects

• Hypoglycemia (low blood sugar)
• Headache
• Weight gain

Serious Risks

• Severe hypoglycemia
• Allergic reactions (rare)

Regular blood sugar monitoring is recommended. For more details, refer to Mayo Clinic – Repaglinide Information.

Contraindications and Precautions

Repaglinide Tablets 1 Mg should not be used in:

• Type 1 diabetes mellitus
• Diabetic ketoacidosis
• Severe liver disease

Use with caution in elderly patients or those prone to hypoglycemia.

Drug Interactions

Repaglinide may interact with other medications affecting blood sugar levels, increasing the risk of hypoglycemia. Patients should inform their healthcare provider about all medicines they are taking. For further reading, refer to American Diabetes Association (ADA).

FAQs